Comparison between Roche and Xpert in HIV-1 RNA quantitation: A high concordance between the two techniques except for a CRF02_AG subtype variant with high viral load titters detected by Roche but undetected by Xpert.
暂无分享,去创建一个
Dan Turner | D. Turner | A. Adler | Boaz Avidor | Natalia Matus | Shirley Girshengorn | Svetlana Achsanov | Simona Gielman | Irene Zeldis | Inbal Schweitzer | Amos Adler | B. Avidor | S. Girshengorn | Natalia Matus | Svetlana Achsanov | Simona Gielman | I. Zeldis | Inbal Schweitzer
[1] P. Ghys,et al. Global trends in molecular epidemiology of HIV-1 during 2000–2007 , 2011, AIDS.
[2] R. Écochard,et al. HIV-1 Load Comparison Using Four Commercial Real-Time Assays , 2010, Journal of Clinical Microbiology.
[3] J. J. Henning,et al. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents, January 28, 2000 , 1998, HIV clinical trials.
[4] R. Camacho,et al. Comparison of the NucliSENS EasyQ HIV-1 v2.0 with Abbott m2000rt RealTime HIV-1 assay for plasma RNA quantitation in different HIV-1 subtypes. , 2013, Journal of virological methods.
[5] G. G. Stokes. "J." , 1890, The New Yale Book of Quotations.
[6] John B. Shoven,et al. I , Edinburgh Medical and Surgical Journal.
[7] Z. Bentwich,et al. Evaluation of a Benchtop HIV Ultradeep Pyrosequencing Drug Resistance Assay in the Clinical Laboratory , 2013, Journal of Clinical Microbiology.
[8] Phuc T. Pham,et al. Significant contribution of subtype G to HIV-1 genetic complexity in Nigeria identified by a newly developed subtyping assay specific for subtype G and CRF02_AG , 2016, Medicine.
[9] R. Peeling,et al. Systematic Review of the Performance of HIV Viral Load Technologies on Plasma Samples , 2014, PloS one.
[10] Jennifer F Hoy,et al. Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society-USA Panel. , 2016, JAMA.
[11] K. Templeton,et al. Comparing HIV viral load assays and frequency of low level virological rebound in clinical practice , 2014, International journal of STD & AIDS.
[12] I. Hewlett,et al. High sensitivity detection of HIV‐1 using two genomic targets compared with single target PCR , 2016, Journal of medical virology.
[13] A. Wu,et al. Multi-site clinical evaluation of the Xpert(®) HIV-1 viral load assay. , 2016, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[14] Z. Grossman,et al. Transmission Patterns of HIV-Subtypes A/AE versus B: Inferring Risk-Behavior Trends and Treatment-Efficacy Limitations from Viral Genotypic Data Obtained Prior to and during Antiretroviral Therapy , 2013, PloS one.
[15] Abou Abdallah Malick Diouara,et al. Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation. , 2015, Journal of virological methods.
[16] C. Delaugerre,et al. Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[17] Sikhulile Moyo,et al. Point-of-Care Cepheid Xpert HIV-1 Viral Load Test in Rural African Communities Is Feasible and Reliable , 2016, Journal of Clinical Microbiology.
[18] Miss A.O. Penney. (b) , 1974, The New Yale Book of Quotations.
[19] L. Sticchi,et al. HIV-1 RNA quantification in CRF02_AG HIV-1 infection: too easy to make mistakes. , 2016, The new microbiologica.
[20] Claudia Arcuri,et al. Xpert HIV-1 Viral Load Assay and VERSANT HIV-1 RNA 1.5 Assay: A Performance Comparison. , 2016, Journal of acquired immune deficiency syndromes.
[21] Orna Mor,et al. Evaluation of the RealTime HIV-1, Xpert HIV-1, and Aptima HIV-1 Quant Dx Assays in Comparison to the NucliSens EasyQ HIV-1 v2.0 Assay for Quantification of HIV-1 Viral Load , 2015, Journal of Clinical Microbiology.
[22] D. Church,et al. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for Determination of HIV-1 Viral Loads in a Cohort of Canadian Patients with Diverse HIV Subtype Infections , 2010, Journal of Clinical Microbiology.
[23] F. Brun-Vézinet,et al. Evaluation of an Upgraded Version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Test for HIV-1 Load Quantification , 2010, Journal of Clinical Microbiology.
[24] Maria Cristina Marazzi,et al. Comparison of the Cepheid GeneXpert and Abbott M2000 HIV-1 real time molecular assays for monitoring HIV-1 viral load and detecting HIV-1 infection. , 2016, Journal of virological methods.
[25] B. Sénéchal,et al. Ten Years of External Quality Assessment of Human Immunodeficiency Virus Type 1 RNA Quantification , 2012, Journal of Clinical Microbiology.
[26] Jean-Christophe Plantier,et al. Performance Evaluation of the New HIV-1 Quantification Assay, Xpert HIV-1 Viral Load, on a Wide Panel of HIV-1 Variants , 2016, Journal of acquired immune deficiency syndromes.
[27] Natasha Samsunder,et al. Diagnostic Accuracy of the Point-of-Care Xpert HIV-1 Viral Load Assay in a South African HIV Clinic , 2016, Journal of acquired immune deficiency syndromes.
[28] A. Geretti,et al. Comparative performance of the new Aptima HIV-1 Quant Dx assay with three commercial PCR-based HIV-1 RNA quantitation assays. , 2015, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[29] A. Haidich,et al. Comparing Abbott m2000 RealTime HIV test and Roche COBAS Ampliprep/COBAS Taqman HIV test, v2.0 in treated HIV‐1 B and non‐B subjects with low viraemia , 2016, Journal of medical virology.
[30] A. Kelleher,et al. Lack of correlation between three commercial platforms for the evaluation of human immunodeficiency virus type 1 (HIV-1) viral load at the clinically critical lower limit of quantification. , 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[31] N. Ford,et al. Early antiretroviral therapy initiation: access and equity of viral load testing for HIV treatment monitoring. , 2017, The Lancet. Infectious diseases.
[32] M. Capobianchi,et al. Ability of Two Commercially Available Assays (Abbott RealTime HIV-1 and Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 Version 2.0) To Quantify Low HIV-1 RNA Levels (<1,000 Copies/Milliliter): Comparison with Clinical Samples and NIBSC Working Reagent for Nucleic Acid Testing Assays , 2014, Journal of Clinical Microbiology.